New-age drug meets resistance

Frank McCormick ()
Additional contact information
Frank McCormick: the UCSF Cancer Center

Nature, 2001, vol. 412, issue 6844, 281-282

Abstract: A new sort of anticancer drug, designed to suppress the wayward protein that causes a type of leukaemia, is under the spotlight. Biological detective work has now revealed how this cancer becomes resistant to the drug.

Date: 2001
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/35085665 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:412:y:2001:i:6844:d:10.1038_35085665

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/35085665

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().